SUMMARY The course of proliferative diabetic retinopathy involving the optic disc was followed, and the response to peripheral retinal photocoagulation monitored by argon laser in 11 patients during and after 13 pregnancies. Traditional obstetric practice assumes that pregnancy is a stimulus to irreversible progression of proliferative diabetic retinopathy, and that timely abortion and sterilisation are essential in order to achieve control of the neovascular process. Extensive photocoagulation will cause significant regression of neovascular complexes in 63 % of cases, and it confers sufficient benefits to make ophthalmic indications for therapeutic abortion and sterilisation no longer tenable.
Taylor and Dobree' stated that between 68 and 73-25% of patients presenting with proliferative diabetic retinopathy have neovascularisation involving the optic disc. In a 3-year study Beetham et al.2 showed that 85% (28 patients) of untreated eyes with vitreous haemorrhage bled from new vessels at the optic disc. This group of patients, exhibiting neovascularisation of the optic disc, inevitably have the poorest prognosis. Consequent on haemorrhage one-third of involved eyes are blind and one-third have permanent impairment of vision within 1 year.3 This is the most serious potential hazard for visual prognosis;4 50% of these diabetic patients are blind within 2 to 3 years. If one eye becomes blind, Patz and Berkow6 have shown that the second (good) eye follows rapidly (50% within 1 year).
New vessels in proliferative diabetic retinopathy tend to progress during 9 months of activity in many cases, and it is therefore difficult to assess the effect of pregnancy on the course of this process. Reports on the subject come to no firm or convincing conclusions, but the risk to vision of rapidly advancing retinopathy during pregnancy has been stated to be high. Diabetic patients have frequently been advised against pregnancy In view of the suggestions of other workers and before any of their results were available a trial was initiated in Manchester in 1973 to attempt elimination of optic-disc neovascularisation in the diabetic patient by peripheral retinal ablation.17 During the course of this study 5 pregnant women were admitted and every attempt was made to contain the proliferative process during their 6 pregnancies. Subsequently 6 more pregnant patients with optic disc neovascularisation were admitted to the group to give a total of 11 women and 13 pregnancies.
Patients and methods
Five pregnant women were entered into a randomised, controlled trial of 94 consecutive patients with a reasonably symmetrical proliferative diabetic retinopathy involving the optic disc. They had a visual acuity which did not differ by more than 2 lines on the Snellen chart and was at least 6/24 in the worse eye. Subsequently a further 6 women with optic disc neovascularisation were grouped with the women from the controlled trial. This latter group either were receiving argon laser photocoagulation when they discovered they were pregnant or commenced treatment soon after this event. No patient was excluded from the study for any of the reasons laid down in the study protocol.17 TECHNIQUE All treated eyes were subjected to extensive peripheral retinal photocoagulation by means of a Coherent 800 gas-argon laser, incorporating a 3 mirror Goldmann lens in the delivery system18 when necessary. The procedure was well tolerated after instillation of local anaesthetic drops in all patients.
Photocoagulation burns were applied within the vascular arcades above and below the macula, but an approximately circular area of radius 2j disc diameters, with the fovea at its centre and including the papillomacular bundle, was left untouched. In the nasal fundus photocoagulation was extended centrally to the edge of the optic disc and involved any new vessels arising from this margin. In all meridians photocoagulation was extended anteriorly to the equator by means of the 3-mirror lens.
Individual burns with sufficient energy to accomplish minimal retinal blanching were applied so that the observer achieved a uniform response over the whole area being treated. Marker burns of 200 ,um diameter were applied to delineate the central area which was to be avoided. Inside the vascular arcades the 200 ,um spot diameter was used. Outside the arcades and nasally, the 500 ,tm spot diameter was used exclusively as far as the periphery. In the nasal sector burns were applied from the nasal edge of the optic disc to the equator in radial rows which followed the direction of the nerve fibres.
Energy levels between 0-2 and 0-6 watt were used, though most burns required 0 35 to 0 45 watt. Inferiorly higher energy levels were required than in any other area of the retina. Lower energies of 0-2 watt were almost invariably adequate within the macular vascular arcades of vessels, where the 200 ,um spot was used. In other areas utilising the 500 ,um spot levels up to 0 5 watt were usually required. To complete treatment over 2000 burns were applied to most patients (range 800 to 3000). The procedure usually required up to 6 sittings over a week.
Retreatment of areas which appeared unduly lightly treated and of any patches of untreated retina within the 'target' area of the ablation procedure was undertaken in patients in whom optic disc neovascularisation persisted.
DATA RECORDED
Patients entering the trial received a full ophthalmic assessment including refraction, tonometry, visual fields, fundus photography, and fluorescein angiography. Patients were not excluded from the study group on the basis of nephropathy or other serious extraocular diabetic problems. However, during and after treatment every attempt was made to achieve good diabetic control by careful medical assessment. The eye to be treated was chosen at random and the untreated eye recorded as a control.
Evaluation of treatment was based on four main criteria: (1) Visual acuity: best corrected visual acuities were obtained at each visit, on subjective testing, by a refractionist who was not aware of the previous visual acuity nor the treated eye. (2) Appearance of the optic discs 6 months after treatment and yearly from that point. Assessment was aided by colour photographs and fluorescein angiograms. (3) For the purposes of the study the 11 pregnant patients were compared with the nonpregnant women contained in the randomised, controlled trial of peripheral retinal ablation.17 Exclusions from the study were made if the patient conformed to one of the following criteria: (i) postmenopausal, at first attendance with proliferative retinal changes; (ii) pregnancy had occurred since proliferative retinal changes were first identified but prior to assessment in our clinic.
Finally the 2 groups of women were compared with all the men entered into the initial randomised, controlled study. The findings are shown in Table 1 . '7 or, in the case of the pregnant women, 6/12 after the end of the gestational period (Figs. 1-6 ).
In the pooled female groups all patients experienced a measurable degree of vessel regression, while the male group had 7-4% of cases in which the neovascular situation either remained stable or deteriorated. A less than significant response was measured in 36-4% of pregnant women, 33% of nonpregnant, and 9.2% of men. A significant improvement in vessel status was recorded in 63-6% of pregnant women, 66% of nonpregnant, and 83% of men (Table 2a, b). Table 3a , b. In the randomised, controlled trial, the mean time to the onset of vitreous haemorrhage from the start of treatment was evaluated in treated and control eyes. The difference in mean time to vitreous haemorrhage, expressed in years, for all treated groups and for the control groups was very highly significant (Mann-Whitney U test, P<O00I). Table 4 outlines the number of eyes in each of the 3 groups which proceeded to blindness within the first 3 years after photocoagulation.
BLIND NESS
In the randomised, controlled trial the difference in proportions between treated and control eyes Fig. 3 X . e -' ---! ' " ; , - There was a statistically significant difference in mean cumulative deterioration of visual acuity between treated and untreated eyes (Table 5) , in the female group studied (Fig. 8) It has not been possible clearly to elucidate an answer to the question, is pregnancy in some way exerting a trigger influence in the proliferative process? What does seem certain is that a considerable proportion of patients who show a progression of retinopathy during pregnancy will show regression after delivery.9-12 Unfortunately, this is clearly not the case in the patients who show proliferative, as opposed to background, retinal changes. This is particularly true in the group presently discussed, where the proliferative changes are the most sinister and vision-threatening of all, because neovascularisation of the optic disc is present.
The present series has shown that, even with a peripheral retinal ablation procedure utilising between 1200 and 2500, 500 ,um spot-diameter impact-burns, a few beneficial effects are conferred. Significant improvement in neovascular status (>50%) at the optic disc occurred in 63-6% of cases. Yet this did significantly reduce the frequency of severe vitreous haemorrhage (> 2 lines fall, in visual acuity, on the Snellen chart). Again, no beneficial or protective effect occurred within 3 years, when eventual visual acuity was examined. There was evidence of a statistically significant difference in mean cumulative deterioration of visual acuity between treated and control eyes over 1-2 years.
Any woman with the retinal vascular problems ensuing from optic disc neovascularisation runs a 92 group.bmj.com on November 7, 2017 -Published by http://bjo.bmj.com/ Downloaded from Peripheral retinal ablation in the treatment ofproliferative diabetic retinopathy during pregnancy grave risk in assuming the added metabolic burden of pregnancy. In the later stages, hypertension and albuminuria may first appear. It is at this point in the pregnancy when proliferative change may appear to be contained by photocoagulation. Yet such reduction in the progressive nature of this process seems to have conferred little benefit visually to the patients examined in this series. If pregnancy is permitted to run its course, scrupulous care is necessary for the successful management of the diabetic. It is thus worthwhile to pursue the potentially protective effects of panretinal photocoagulation with a more extensive form of application (up to 6000 impact burns) than described in the patients from this series. It is the authors' considered opinion that therapeutic abortion and sterilisation are not justified for ophthalmic reasons. 
